Changing A Name: More Than An Academic Exercise
People living with NASH, patients and families, whose lives and livelihoods are at risk from a liver disease few outside of a small circle of academic and clinical experts had heard of a few years ago have very practical, urgent needs:
Disease education/awareness (for patients, providers, payers, policymakers)
Development and designation of simplified non-invasive testing and expanded screening (get beyond the biopsy)
FDA-approval of NASH drugs, devices, and diagnostics (find a treatment)
Clinical environments organized to provide coordinated integrated care to people at every stage of the NAFLD-NASH spectrum
Read More
The Road to #NASHday: Guidelines, Roadmaps, & Actions for Today
Did you know that the U.S. NASH Action Plan is the first and only national action plan created to address the growing epidemic of NASH?
In 2021, GLI NASH Council partners collaborated to draft this set of actionable recommendations for the full spectrum of stakeholders involved in NASH prevention and treatment, including: patients and caregivers, clinicians, patient advocacy organizations, medical societies, industry, policymakers, regulators, health systems, and health insurance payers. Each critical intervention within this plan plays a vital role in elevating NASH to its rightful place on the national public health agenda commensurate with its prevalence and impact.
Read More
New Year, Fresh Perspectives
Fatty liver disease (FLD) and nonalcoholic steatohepatitis (NASH) are increasing in prevalence worldwide, creating a major global public health crisis. To adequately educate patients, practitioners, and policymakers, there is a need to collect, curate and share relevant information. NASH News, published on behalf of the Global Liver Institute’s NASH Council, intends to meet that need and to facilitate collaboration across the emerging NASH community on a monthly basis.
Read More
